{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T19:49:29Z","timestamp":1771962569559,"version":"3.50.1"},"reference-count":62,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2006,6,23]],"date-time":"2006-06-23T00:00:00Z","timestamp":1151020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hemodialysis International"],"published-print":{"date-parts":[[2006,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Optimal phosphate control in dialysis patients is extremely challenging. A growing awareness of the deleterious effect of mineral metabolism imbalances together with the lack of a satisfactory explanation for the exaggerated mortality rate in patients undergoing renal replacement therapy has led to a renewed effort to refine our approach to hyperphosphatemia. However, despite the remarkable improvements in dialysis techniques, phosphate control has not substantially improved. Achieving normo\u2010phosphatemia presents a multitude of practical and scientific challenges related to the optimal target level, cardiovascular health, and drug toxicities. It is the aim of the present review to summarize briefly the controversies associated with currently available phosphate binders, a cornerstone in the current management of hyperphosphatemia.<\/jats:p>","DOI":"10.1111\/j.1542-4758.2006.00100.x","type":"journal-article","created":{"date-parts":[[2006,6,23]],"date-time":"2006-06-23T09:33:12Z","timestamp":1151055192000},"page":"225-234","source":"Crossref","is-referenced-by-count":37,"title":["Phosphate binders: New products and challenges"],"prefix":"10.1111","volume":"10","author":[{"given":"Antonio","family":"BELLASI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"KOOIENGA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey A.","family":"BLOCK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,6,23]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004030203"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000133041.27682.A2"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(04)01103-5"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)01070-9"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.07.022"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00600.x"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01781-8"},{"key":"e_1_2_8_9_2","first-page":"1","article-title":"Vascular calcification and cardiovascular function in chronic kidney disease","volume":"21","author":"Sigrist M","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_8_10_2","first-page":"29","article-title":"Phosphate control in chronic uremia","volume":"16","author":"Cupisti A","year":"2003","journal-title":"Don't forget diet"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00072.2005"},{"key":"e_1_2_8_12_2","first-page":"1","volume-title":"Maintenance Dialysis: Evaluation of Protein\u2010Energy Nutritional Status","author":"Kidney Foundation.","year":"2000"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.27578"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/hy1001.096358"},{"key":"e_1_2_8_15_2","first-page":"159","article-title":"Cardiac valve calcification as an important predictor for all\u2010cause mortality and cardiovascular mortality in long\u2010term peritoneal dialysis patients","volume":"13","author":"Wang AY\u2010M","year":"2003","journal-title":"A prospective study"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.553198"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004070602"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.87.7.e10"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000216409.20863.e7"},{"issue":"78","key":"e_1_2_8_20_2","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.1046\/j.1523-1755.2001.59780190.x","article-title":"Phosphate removal and hemodialysis conditions","volume":"59","author":"Pohlmeier R","year":"2001","journal-title":"Kidney Int"},{"key":"e_1_2_8_21_2","article-title":"Phosphate kinetics during high\u2010flux hemodialysis","author":"Desoi CA","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_8_22_2","first-page":"655","article-title":"Phosphate kinetics during hemodialysis","volume":"61","author":"Spalding EM","year":"2002","journal-title":"Evidence for biphasic regulation"},{"key":"e_1_2_8_23_2","first-page":"2778","article-title":"Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers","volume":"16","author":"Ayus JC","year":"2005","journal-title":"A prospective, controlled study"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.00875.x"},{"issue":"3","key":"e_1_2_8_25_2","first-page":"171","article-title":"Toxic effects of aluminum in ESRD","volume":"12","author":"Coburn JW","year":"1988","journal-title":"Discussion of a case"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.suppl_2.21"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197601222940402"},{"key":"e_1_2_8_28_2","first-page":"342","article-title":"Clinical and laboratory features of aluminum\u2010related bone disease","volume":"6","author":"Norris K","year":"1985","journal-title":"Differences between sporadic and \u201cepidemic\u201d forms of the syndrome"},{"key":"e_1_2_8_29_2","first-page":"1091","article-title":"Lanthanum carbonate (Fosrenol (R))","volume":"59","author":"Albaaj F","year":"2005","journal-title":"A novel agent for the treatment of hyperphosphataemia in renal failure and dialysis patients"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh693"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00171.x"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00753.x"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.63.s85.18.x"},{"key":"e_1_2_8_34_2","first-page":"96","article-title":"Randomized, double\u2010blind, placebo\u2010controlled, dose\u2010titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate","volume":"42","author":"Joy MS","year":"2003","journal-title":"A new phosphate binder for the treatment of hyperphosphatemia"},{"key":"e_1_2_8_35_2","first-page":"688","article-title":"Lanthanum carbonate shire","volume":"6","author":"Locatelli F","year":"2003","journal-title":"IDrugs"},{"key":"e_1_2_8_36_2","first-page":"c8","article-title":"Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia","volume":"100","author":"Hutchison AJ","year":"2005","journal-title":"A 6-month, randomized, comparative trial versus calcium carbonate"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X41453"},{"key":"e_1_2_8_38_2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1681\/ASN.V3196","article-title":"Calcium acetate as a phosphorus binder in hemodialysis patients","volume":"3","author":"Delmez JA","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_8_39_2","first-page":"35","article-title":"Alternative phosphate binders in dialysis patients","volume":"6","author":"Slatopolsky EA","year":"1986","journal-title":"Calcium carbonate"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(01)80079-2"},{"key":"e_1_2_8_41_2","first-page":"2857","article-title":"Human vascular smooth muscle cells undergo vesicle mediated calcification in response to changes in extracellular calcium and phosphate concentrations","volume":"15","author":"Reynolds JL","year":"2004","journal-title":"A potential mechanism for accelerated vascular calcification in ESRD"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.66015.x"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005183422003"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh125"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00434.x"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000129337.50739.48"},{"key":"e_1_2_8_47_2","first-page":"248","article-title":"Calcium use increases the risk of calciphylaxis","volume":"19","author":"Zacharias JM","year":"1999","journal-title":"A case-control study"},{"key":"e_1_2_8_48_2","first-page":"2210","article-title":"Calciphylaxis is usually non\u2010ulcerating","volume":"61","author":"Fine A","year":"2002","journal-title":"Risk factors, outcome and therapy"},{"key":"e_1_2_8_49_2","first-page":"1","article-title":"Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density","author":"Asmus H\u2010G","year":"2005","journal-title":"Nephrol Dial Transpl"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.041221"},{"key":"e_1_2_8_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.12.2907"},{"key":"e_1_2_8_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20781"},{"key":"e_1_2_8_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.07.023"},{"key":"e_1_2_8_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00233.x"},{"key":"e_1_2_8_55_2","first-page":"265","article-title":"An open label crossover study of a new phosphate binding agent in hemodialysis patients","volume":"17","author":"Yang W","year":"2002","journal-title":"Ferric citrate"},{"key":"e_1_2_8_56_2","first-page":"1274","article-title":"New phosphate binding agents","author":"Hsu CH","year":"1999","journal-title":"Ferric compounds"},{"key":"e_1_2_8_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70362-8"},{"key":"e_1_2_8_58_2","first-page":"513","article-title":"The evaluation of novel mixed metal hydroxycarbonates as phosphate binders","author":"Rankin BJ","year":"2001","journal-title":"An in-vivo study in rats"},{"key":"e_1_2_8_59_2","first-page":"53","article-title":"Different mg to Fe ratios in the mixed metal mg","volume":"91","author":"Zhu H","year":"2002","journal-title":"Fe hydroxy-carbonate compounds and the effect on phosphate binding compared with established phosphate binders"},{"key":"e_1_2_8_60_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00482.x"},{"key":"e_1_2_8_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh781"},{"key":"e_1_2_8_62_2","first-page":"424","article-title":"Effect of MCI\u2010196 (colestilan) as a phosphate binder on hyperphosphataemia in hemodialysis patients","volume":"20","author":"Kurihara S","year":"2005","journal-title":"A double-blind, placebo-controlled, short term trial"},{"key":"e_1_2_8_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.67139.x"}],"container-title":["Hemodialysis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1542-4758.2006.00100.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1542-4758.2006.00100.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T09:17:21Z","timestamp":1697015841000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1542-4758.2006.00100.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,23]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["10.1111\/j.1542-4758.2006.00100.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1542-4758.2006.00100.x","archive":["Portico"],"relation":{},"ISSN":["1492-7535","1542-4758"],"issn-type":[{"value":"1492-7535","type":"print"},{"value":"1542-4758","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,23]]}}}